These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38853507)

  • 41. Mechanisms of alpha-synuclein toxicity: An update and outlook.
    Brás IC; Xylaki M; Outeiro TF
    Prog Brain Res; 2020; 252():91-129. PubMed ID: 32247376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha Synuclein: Neurodegeneration and Inflammation.
    Forloni G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein Quality Control Pathways at the Crossroad of Synucleinopathies.
    De Mattos EP; Wentink A; Nussbaum-Krammer C; Hansen C; Bergink S; Melki R; Kampinga HH
    J Parkinsons Dis; 2020; 10(2):369-382. PubMed ID: 31985474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Propagation of Distinct α-Synuclein Strains Within Human Reconstructed Neuronal Network and Associated Neuronal Dysfunctions.
    Gribaudo S; Bousset L; Courte J; Melki R; Peyrin JM; Perrier AL
    Methods Mol Biol; 2023; 2551():357-378. PubMed ID: 36310215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies.
    Fayyad M; Majbour NK; Vaikath NN; Erskine D; El-Tarawneh H; Sudhakaran IP; Abdesselem H; El-Agnaf OMA
    Neurosci Lett; 2020 Apr; 725():134899. PubMed ID: 32156613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
    Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
    Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease.
    Er S; Airavaara M
    Biochem Soc Trans; 2023 Feb; 51(1):245-257. PubMed ID: 36794783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward a Disease-Modifying Therapy of Alpha-Synucleinopathies: New Molecules and New Approaches Came into the Limelight.
    Upcott M; Chaprov KD; Buchman VL
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular events underlying the cell-to-cell transmission of α-synuclein.
    Choi YR; Park SJ; Park SM
    FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
    Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
    Zheng T; Zhang Z
    Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid macropinocytic transfer of α-synuclein to lysosomes.
    Bayati A; Banks E; Han C; Luo W; Reintsch WE; Zorca CE; Shlaifer I; Del Cid Pellitero E; Vanderperre B; McBride HM; Fon EA; Durcan TM; McPherson PS
    Cell Rep; 2022 Jul; 40(3):111102. PubMed ID: 35858558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
    Brumberg J; Kuzkina A; Lapa C; Mammadova S; Buck A; Volkmann J; Sommer C; Isaias IU; Doppler K
    Neurobiol Dis; 2021 Jun; 153():105332. PubMed ID: 33722614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy.
    Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P
    J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
    Angot E; Brundin P
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S143-7. PubMed ID: 20082977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein.
    Kang SJ; Kim SJ; Noh HR; Kim BJ; Kim JB; Jin U; Park SA; Park SM
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prion Properties of Alpha-Synuclein].
    Schwarzman AL; Senkevich KA; Emelyanov AK; Pchelina SN
    Mol Biol (Mosk); 2019; 53(3):380-387. PubMed ID: 31184602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease.
    Li Y; Wang T; Meng L; Jin L; Liu C; Liang Y; Ren L; Liu Y; Liu Y; Liu S; Li T; Liang Y; Chen X; Zhang Z
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12860. PubMed ID: 36331758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
    Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M
    J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.